Emerging role of endothelial and inflammatory markers in preeclampsia

Menha Swellam1, Nervana Samy, Susan Abdl Wahab

  • 1Department of Biochemistry, Genetic Engineering and Biotechnology Research Division, National Research Center, Dokki, Giza, Egypt. menha_m_swellam@yahoo.com

Disease Markers
|July 15, 2009
PubMed

Insights

This study found that combining thrombomodulin (TM), plasminogen activator inhibitor-1 (PAI-1), C-reactive protein (CRP), and interleukin-6 (IL-6) offers a sensitive diagnostic approach for pre-eclampsia (PE). Specifically, PAI-1 combined with CRP demonstrated superior sensitivity and specificity for PE detection.

Area of Science:

  • Biochemistry
  • Immunology
  • Obstetrics

Background:

  • Pre-eclampsia (PE) involves endothelial dysfunction and heightened inflammation.
  • Accurate diagnostic markers are crucial for managing PE.

Purpose of the Study:

  • To evaluate the diagnostic utility of thrombomodulin (TM), plasminogen activator inhibitor-1 (PAI-1), C-reactive protein (CRP), and interleukin-6 (IL-6) in pre-eclampsia.
  • To assess these markers individually and in combination for pre-eclampsia detection.

Main Methods:

  • Retrospective analysis of 185 women (80 with PE, 55 normotensive pregnant, 50 healthy non-pregnant).
  • Plasma levels of TM, PAI-1, CRP, and IL-6 measured via enzyme-linked immunosorbent assays.

Main Results:

  • All markers showed significantly higher levels and positivity rates in the PE group (P < 0.0001).
  • PAI-1 exhibited the highest individual sensitivity (98%).
  • Combining markers achieved 100% sensitivity, with PAI-1 and CRP combination showing 83% specificity.

Conclusions:

  • Endothelial and inflammatory markers are sensitive indicators for pre-eclampsia diagnosis.
  • The combination of PAI-1 and CRP presents a promising, highly sensitive, and specific method for pre-eclampsia detection.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...